GlassScriptPhysician profile
Danielle H Heck
NPI 1023480753
$5,701.97
in general payments reported to CMS, 2019-2025
51 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 91% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $633 · 2022: $1,265 · 2023: $1,180 · 2024: $1,303 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,804.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $865.85 | 2021-2025 | |
| Novo Nordisk INC | $838.60 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $518.82 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.62 | 2021-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $301.73 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $285.77 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.34 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $188.74 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $138.60 | 2021-2022 | |
| Astellas Pharma US INC | $128.96 | 2022-2025 | Veozah |
| Pfizer INC. | $122.74 | 2023-2025 | |
| Azurity Pharmaceuticals, INC. | $119.43 | 2023-2025 | Horizant, Azmiro, Horizant |
| Seqirus USA INC | $118.79 | 2023-2025 | Fluad, Flucelvax, Flucelvax Quadrivalent |
| Phathom Pharmaceuticals, INC. | $113.26 | 2024-2025 | Voquezna |
| Esperion Therapeutics, INC. | $103.16 | 2021-2024 | Nexletol |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $100.45 | 2024-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $98.38 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $95.29 | 2021-2022 | |
| Antares Pharma, INC. | $69.54 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Dexcom, INC. | $61.55 | 2024-2025 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $60.36 | 2021-2022 | |
| Amgen INC. | $59.46 | 2025 | Repatha, Otezla |
| Abbott Laboratories | $44.04 | 2022-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $40.71 | 2021-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $39.96 | 2021-2022 | |
| Avvisto Therapeutics, LLC | $37.84 | 2025 | Cycloset |
| Nevro Corp. | $31.94 | 2023-2024 | Senza |
| Renalytix Ai, INC. | $31.68 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Aimmune Therapeutics, INC. | $30.75 | 2024 | |
| Si-Bone, INC. | $25.93 | 2025 | |
| Inari Medical, INC. | $25.56 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.04 | 2024 | Xifaxan |
| Heartflow, INC. | $23.43 | 2023 | Ffrct |
| Biogen, INC. | $22.77 | 2021 | |
| Dynavax Technologies Corporation | $21.35 | 2023 | Heplisav-B |
| Philips North America LLC | $20.62 | 2024 | (Ck7) Extended Holter |
| Nestle Healthcare Nutrition INC. | $20.30 | 2021 | |
| Medtronic, INC. | $19.25 | 2025 | Inceptiv |
| Boston Scientific Corporation | $18.04 | 2022 | |
| Althera Pharmaceuticals LLC | $17.46 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $17.35 | 2024 | Crysvita |
| Siemens Medical Solutions USA, INC. | $17.31 | 2024 | Magnetom Skyra |
| Xeris Pharmaceuticals, INC. | $16.16 | 2023 | Keveyis |
| Tolmar, INC. | $15.96 | 2025 | Jatenzo |
| Sanofi-Aventis U.S. LLC | $15.38 | 2022 | |
| Madrigal Pharmaceuticals | $14.98 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $14.71 | 2024 | Cologuard Collection Kit |
| Halozyme INC | $14.14 | 2023 | |
| Alfasigma USA, INC. | $13.79 | 2021 | |
| Currax Pharmaceuticals LLC | $13.73 | 2023 | Onzetra Xsail, Contrave |
| Linus Health, INC. | $13.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Heck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.